Literature DB >> 18813761

High prevalence of hepatitis B virus among female sex workers in Nigeria.

J C Forbi1, N Onyemauwa, S D Gyar, A O Oyeleye, P Entonu, S M Agwale.   

Abstract

Hepatitis B virus (HBV) infection is endemic in Nigeria and constitutes a public health menace. The prevalence of HBV infection in many professional groups has been described in Nigeria. However, literature on HBV infection among female sex workers (FSW) in Nigeria is scanty. FSW in Nigeria are not subjected to a preventive control of HBV infection. This study assesses the extent of spread of HBV among FSW in Nigeria. Seven hundred and twenty (n = 720) FSW (mean age = 26.7 years) were tested for hepatitis B surface antigen (HBsAg) by a double antibody sandwich ELISA method. The overall HBV prevalence among the FSW was 17.1%. FSWs between the ages of 31-35 year (20.5%) and those with 'age-at-first-sex' below 10 years of age (28%) were most affected. This high prevalence of a vaccine preventable disease is unacceptable, therefore, vaccination of this high risk HBV reservoir group should be considered worthwhile.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813761     DOI: 10.1590/s0036-46652008000400006

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  21 in total

1.  Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa.

Authors:  Felicia Wu; Pornsri Khlangwiset
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-05

2.  A Study on the HBV and the HCV Infections in Female Sex Workers and their Co-Infection with HIV.

Authors:  Desai Praseeda S; Dutta Anuradha; Shastri Jayanthi S
Journal:  J Clin Diagn Res       Date:  2013-02-01

3.  Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventions.

Authors:  F Wu; P Khlangwiset
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-04

4.  Seroprevalence of Hepatitis B Virus and Associated Factors Among Female Sex Workers Using Respondent-Driven Sampling in Hawassa City, Ethiopia.

Authors:  Deresse Daka; Getahun Hailemeskel; Demissie Assegu Fenta
Journal:  Infect Drug Resist       Date:  2021-10-20       Impact factor: 4.003

5.  Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.

Authors:  Adebola T Olayinka; Akin Oyemakinde; Muhammad S Balogun; Anthonia Ajudua; Patrick Nguku; Moses Aderinola; Abiodun Egwuenu-Oladejo; Simeon W Ajisegiri; Samuel Sha'aibu; Bolanle O P Musa; Saheed Gidado; Abdulsalami Nasidi
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

6.  Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria.

Authors:  Joseph C Forbi; Gilberto Vaughan; Michael A Purdy; David S Campo; Guo-liang Xia; Lilia M Ganova-Raeva; Sumathi Ramachandran; Hong Thai; Yury E Khudyakov
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

7.  Prevalence of Hepatitis B Surface Antigen and Antibodies to Hepatitis C in the General Population of Benue State, Central Nigeria.

Authors:  Abraham O Malu; Godwin I Achinge; Priscilla M Utoo; Jonathan T Kur; Solomon A Obekpa
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

8.  HIV-related risk perception among female sex workers in Nigeria.

Authors:  Augustine Ankomah; Godpower Omoregie; Zacch Akinyemi; Jennifer Anyanti; Olaronke Ladipo; Samson Adebayo
Journal:  HIV AIDS (Auckl)       Date:  2011-07-27

9.  Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors.

Authors:  Nazila Kassaian; Behrooz Ataei; Majid Yaran; Anahita Babak; Parisa Shoaei
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

10.  Prevalence of hepatitis B e antigen in chronic HBV carriers in North-central Nigeria.

Authors:  Joseph C Forbi; Odunayo H Iperepolu; Timothy Zungwe; Simon M Agwale
Journal:  J Health Popul Nutr       Date:  2012-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.